We are live on ! Find out more
AMRX icon

Amneal Pharmaceuticals
AMRX

248 hedge funds and large institutions have $1.51B invested in Amneal Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 97 increasing their positions, 73 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

33% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 73

31% more capital invested

Capital invested by funds: $1.16B → $1.51B (+$354M)

30% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 30

3% more funds holding

Funds holding: 241 → 248 (+7)

2.44% more ownership

Funds ownership: 45.57% → 48.01% (+2.4%)

Holders
248
Holders Change
+7
Holders Change %
+2.9%
% of All Funds
3.25%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
39
Increased
97
Reduced
73
Closed
30
Calls
$6.94M
Puts
–
Net Calls
+$6.94M
Net Calls Change
+$5.71M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$17.4M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$12.6M
3
WW
Westshore Wealth
California
+$12.4M
4
Allspring Global Investments
Allspring Global Investments
North Carolina
+$9.53M
5
Morgan Stanley
Morgan Stanley
New York
+$9.03M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$15.4M
2
BCP
BlackBarn Capital Partners
New York
-$11.3M
3
JP Morgan Chase
JP Morgan Chase
New York
-$5.04M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$3.59M
5
HF
HRT Financial
New York
-$3.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
FFA
226
Farther Finance Advisors
California
$1.49K +$1.25K +139 +1,390%
PA
227
Parallel Advisors
California
$1.31K – – –
Federated Hermes
228
Federated Hermes
Pennsylvania
$1.29K +$431 +48 +59%
GLF
229
Groupe la Francaise
France
$1.26K +$1.35K +150 New
GWSG
230
GPS Wealth Strategies Group
Colorado
$1.15K – – –
PMAM
231
Picton Mahoney Asset Management
Ontario, Canada
$1K – – –
JWA
232
JFS Wealth Advisors
Pennsylvania
$701 +$72 +8 +13%
PFBT
233
Parkside Financial Bank & Trust
Missouri
$661 – – –
CMBA
234
C.M. Bidwell & Associates
Hawaii
$651 – – –
NSIM
235
North Star Investment Management
Illinois
$601 – – –
Jones Financial Companies
236
Jones Financial Companies
Missouri
$488 – – –
TWD
237
True Wealth Design
Ohio
$411 +$350 +39 +1,950%
CPG
238
Cornerstone Planning Group
New Jersey
$400 – – –
SS
239
SBI Securities
Japan
$400 +$18 +2 +5%
SVCP
240
Silicon Valley Capital Partners
California
$300 – – –
WANY
241
Wealthspire Advisors (New York)
New York
$240 +$215 +24 New
DPW
242
DiNuzzo Private Wealth
Pennsylvania
$211 – – –
SIC
243
SJS Investment Consulting
Ohio
$171 +$153 +17 New
RWM
244
Rialto Wealth Management
New York
$141 +$99 +11 +367%
BHWM
245
Bay Harbor Wealth Management
Maryland
$140 +$108 +12 +600%
HIA
246
HFM Investment Advisors
New Jersey
$90 – – –
HF
247
HRT Financial
New York
– -$3.54M -437,330 Closed
TI
248
Trexquant Investment
Connecticut
– -$1.44M -177,513 Closed
DFCM
249
Dark Forest Capital Management
Puerto Rico
– -$1.29M -159,040 Closed
NRD
250
Nebula Research & Development
New York
– -$984K -121,599 Closed
8 9
10
11 12

AMRX Hedge Fund Activity: Q3 2025 in Review

248 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Amneal Pharmaceuticals (AMRX) for Q3 2025, worth a combined $1.51B — up 31% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new AMRX positions and 30 closed out — a net gain of 9 holders — while 97 added to existing stakes and 73 trimmed.

The largest buyer was BlackRock, adding an estimated $17.4M. The largest seller was Millennium Management, cutting an estimated $15.4M.

  • 248 institutional investors held Amneal Pharmaceuticals (AMRX) as of Q3 2025, up from 241 in Q2 2025.
  • Funds reported $1.51B of Amneal Pharmaceuticals stock for Q3 2025, up 31% quarter-over-quarter.
  • 39 funds opened new Amneal Pharmaceuticals positions in Q3 2025 and 30 closed out, a net change of +9 holders.
  • The largest Amneal Pharmaceuticals buyer in Q3 2025 was BlackRock, an estimated $17.4M added.
  • The largest Amneal Pharmaceuticals seller in Q3 2025 was Millennium Management, an estimated $15.4M sold.

Based on aggregated 13F filings for Q3 2025.